Equities

Hua Medicine

Hua Medicine

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)1.15
  • Today's Change-0.04 / -3.36%
  • Shares traded1.20m
  • 1 Year change-28.13%
  • Beta1.5907
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,461491675
Total Receivables, Net114150.41
Total Inventory451.92--
Prepaid expenses492114
Other current assets, total7.041215
Total current assets1,572940705
Property, plant & equipment, net115140157
Goodwill, net------
Intangibles, net29329.03
Long term investments------
Note receivable - long term1.671.1325
Other long term assets4.995.325.26
Total assets1,7251,121904
LIABILITIES
Accounts payable522124
Accrued expenses374034
Notes payable/short-term debt0340
Current portion long-term debt/capital leases412113
Other current liabilities, total1227236
Total current liabilities252188107
Total long term debt1264258
Total debt1689872
Deferred income tax------
Minority interest------
Other liabilities, total1,246611288
Total liabilities1,624842453
SHAREHOLDERS EQUITY
Common stock7.217.217.21
Additional paid-in capital5,9315,9225,910
Retained earnings (accumulated deficit)(5836)(5649)(5467)
Treasury stock - common(0.51)(0.58)(0.63)
Unrealized gain (loss)------
Other equity, total(0.2)0.100.00
Total equity101280450
Total liabilities & shareholders' equity1,7251,121904
Total common shares outstanding981970964
Treasury shares - common primary issue758592
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.